Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intercept Pharmaceuticals
(NQ:
ICPT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intercept Pharmaceuticals
< Previous
1
2
3
4
5
6
7
Next >
CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
February 13, 2024
Gilead's acquisition of CymaBay Therapeutics for $4.3 billion strengthens its liver disease portfolio. Analysts see potential in seladelpar's impact on PBC and pruritus, projecting peak sales of $800...
Via
Benzinga
Top 5 Health Care Stocks That Should Keep You Up At Night
October 26, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Stocks to Sell: 7 Overbought Companies You Ought to Dump Right Now
October 19, 2023
Overbought stocks are an early indication of a potential correction on a stock; act now if you hold these stocks.
Via
InvestorPlace
INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT
October 16, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Analyst Expectations for Intercept Pharma's Future
September 27, 2023
Via
Benzinga
Analyst Ratings for Intercept Pharma
August 03, 2023
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –
October 03, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 28, 2023
Via
Benzinga
INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT
September 27, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
Via
Benzinga
Why Intercept Pharmaceuticals Stock Is Skyrocketing Today
September 26, 2023
Intercept is on track to be acquired by Alfasigma at a significant premium compared to recent prices.
Via
The Motley Fool
Why Is Intercept Pharmaceuticals (ICPT) Stock Up 75% Today?
September 26, 2023
Although Intercept Pharmaceuticals popped higher on a buyout deal, many stakeholders of ICPT stock are left wondering what might have been.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 26, 2023
Via
Benzinga
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 26, 2023
Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...
Via
Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Intercept Pharmaceuticals, Inc. (Nasdaq – ICPT), Splunk, Inc. (Nasdaq – SPLK), Applied Molecular Transport Inc. (Nasdaq - AMTI), NextGen Healthcare, Inc. (Nasdaq –
September 26, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) is a Leading Gainer in Tuesday Morning Trading
September 26, 2023
Via
Investor Brand Network
Dow Tumbles 150 Points; US House Prices Rise in July
September 26, 2023
U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.45% to 33,852.58 while the NASDAQ fell 0.74%...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Rare Liver Disease Focused Intercept Pharmaceuticals Stock Trading Higher Today?
September 26, 2023
Italy-based Alfasigma has agreed to acquire Intercept Pharmaceuticals Inc (NASDAQ: ICPT) for
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 26, 2023
Via
Benzinga
ICPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intercept Pharmaceuticals, Inc. Is Fair to Shareholders
September 26, 2023
From
Halper Sadeh LLC
Via
Business Wire
Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 22, 2023
Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.
Via
Benzinga
Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
September 21, 2023
Thursday, CymaBay Therapeutics Inc (NASDAQ: CBAY) initiated the AFFIRM Phase 3b/4 confirmatory study to evaluate the effect of seladelpar on clinical outcomes in patients with compensated cirrhosis due...
Via
Benzinga
Why CymaBay Therapeutics Stock Is Jumping Today
September 08, 2023
The momentum continues after CymaBay reported great clinical results on Thursday.
Via
The Motley Fool
Why CymaBay, With 172% Growth This Year, Just Surged For A Second Day Running
September 08, 2023
The company is working on a treatment for a liver disease that can cause severe itching.
Via
Investor's Business Daily
Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business
July 13, 2023
HC Wainwright has upgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) to Buy from Sell, with a price target of
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023
July 13, 2023
Via
Benzinga
Madrigal Stock Pops As It Makes Inroads Into What Could Be A $160 Billion Market
June 30, 2023
Madrigal is working on gaining FDA approval for what could be the first NASH treatment.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023
June 29, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.